Nordic Bioscience AS
Dr. Anne Bay-Jensen is the Director of the ImmunoScience group at Nordic Bioscience – a group focused on developing novel biomarkers and testing them in clinical cohorts and translational models. Anne has been working in the OA field since 2003, where she started her PhD work, investigating cartilage changes as a function of OA. Although OA is not the only focus area of the ImmunoScience group, it is the area where Anne spends her personal research time. Anne’s main interest is development, testing and validation of markers that may subgroup patients based on their disease pathotype using soluble biomarkers reflecting tissue remodeling.